Stage III Papillary Thyroid Cancer
4 clinical trials · Condition
◉ Watch Stage III Papillary Thyroid Cancer
| Record | Firm | Date |
|---|---|---|
| Central Neck Dissection in Patients With Clinical Node Negative Thyroid Cancer (NCT02138214) | University of Wisconsin, Madison | 2014-06-06 |
| Sorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer (NCT00095693) | National Cancer Institute (NCI) | 2004-10-01 |
| Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer (NCT00068497) | National Cancer Institute (NCI) | 2003-08-01 |
| Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu (NCT00004074) | National Cancer Institute (NCI) | 1999-08-01 |
Track Stage III Papillary Thyroid Cancer automatically
Every clearance here is in the API, with alerts when new ones post.